4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Acumen Pharmaceuticals, Inc. (ABOS) operates in the Biotechnology industry and is headquartered in Newton, United States with about 60 employees. Its market capitalization is roughly $157 million. In the fiscal year ended 2025-12-31, ABOS reported $0M in revenue and ($121M) in net income.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($124M) | ($114M) | ($61M) | ($45M) | — |
| Net Income | ($121M) | ($102M) | ($52M) | ($43M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($21M) | ($25M) | ($26M) | ($42M) | ($30M) |
| Net Income | ($21M) | ($25M) | ($26M) | ($41M) | ($29M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | $0M | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $123M | $239M | $310M | $197M | — |
| Total Liabilities | $52M | $57M | $43M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABOS viewer.
About TickerBase · Data methodology & sources